KNVA
Keenova Reports Q3 2026 Financial Results
Third-quarter net sales from continuing operations reached $550 million. The results supported updated guidance for Acthar Gel and XIAFLEX growth.
KNVA news
Latest 1 stories · newest Nov 10, 2026
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same KNVA feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/KNVA/newsSTART FREE